VICENTI ILARIA

Ilaria
Vicenti
Ricercatore Legge 240/10 - tempo determinato

Contacts

Teaching activities

Completion accademic year: 2021/2022

Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2021/2022

Completion accademic year: 2020/2021

Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2020/2021

Research

Ultime pubblicazioni:

  • Vicenti, I., Dragoni, F., Monti, M., Trombetta, C.M., Giannini, A., Boccuto, A., et al. (2021). Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells. JOURNAL OF GENERAL VIROLOGY, 102(1) [10.1099/jgv.0.001499]. - view more
  • Manini, I., Camarri, A., Marchi, S., Trombetta, C.M., Vicenti, I., Dragoni, F., et al. (2021). Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in tuscany, Italy. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(8), 1-8. - view more
  • Vicenti, I., Gatti, F., Scaggiante, R., Boccuto, A., Zago, D., Basso, M., et al. (2021). The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects. INFECTION, 1-3 [10.1007/s15010-021-01680-z]. - view more
  • Vicenti, I., Martina, M.G., Boccuto, A., De Angelis, M., Giavarini, G., Dragoni, F., et al. (2021). System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 224, 113683 [10.1016/j.ejmech.2021.113683]. - view more
  • Vicenti, I., Gatti, F., Scaggiante, R., Boccuto, A., Zago, D., Basso, M., et al. (2021). Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 108, 176-178-178. - view more